Case Report: Haemolytic anaemia with ceftazidime use in a patient with cystic fibrosis

Drug-induced Immune Haemolytic Anaemia (DIIHA) is a rare but serious complication of cephalosporin use. Ceftazidime is recognized to be a rare cause of DIIHA. We report and discuss a case of DIIHA in a person with cystic fibrosis who developed severe haemolytic anaemia following use of ceftazidime i...

Descripción completa

Detalles Bibliográficos
Autores principales: Yong, Jun, Frost, Freddy, Nazareth, Dilip, Walshaw, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920311/
https://www.ncbi.nlm.nih.gov/pubmed/29770214
http://dx.doi.org/10.12688/f1000research.14505.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920311/
https://www.ncbi.nlm.nih.gov/pubmed/29770214
http://dx.doi.org/10.12688/f1000research.14505.1

Ejemplares similares